Prednisone group (n = 21) | Placebo group (n = 19) | ||
---|---|---|---|
Age, years – median (range) | 5 (2–11) | 6.1 (3–15) | |
Gender | Female | 8 | 12 |
Male | 13 | 7 | |
Ethnicity | Caucasian | 18 | 18 |
Other | 3 | 1 | |
Days since illness onset – median (range) | 4 (1–7) | 3 (1–7) | |
Symptoms at enrollment- number of subjects (%) | Rash | 21 (100) | 19 (100) |
Joint | 17 (81) | 18 (95) | |
Gastrointestinal | 18 (86) | 11 (58) | |
Renal | 4 (19) | 2 (11) |